Displaying 1-20 of 246 results for

Sept. 27, 2022, ASTHO Legislative Alert: analysis of Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 (H.R. 6833).

Public Health Officials Stand Ready to Implement White House Xylazine Response Plan ARLINGTON, VA—The Association of State and Territorial Health Officials (ASTHO) CEO Michael Fraser, PhD, made the following statement regarding ...

On May 11, 2023, ASTHO announced it had filed an amicus brief with the Supreme Court of North Carolina asserting that a public health official must be empowered to take quick action to protect the public health and safety of their ...

On Nov. 22, 2021, ASTHO President Nirav Shah, MD was an invited speaker at a Public Health Community Appreciation Town Hall, organized by the White House. He gave brief remarks of appreciation for the entire public health workforce.

On Aug. 12, 2021, ASTHO announced that Kimberlee D. Wyche-Etheridge, MD, MPH, will serve as the organization’s senior vice president of health equity and diversity initiatives, effective Oct. 4, 2021.

On July 13, 2021, ASTHO issued a statement of support for President Joe Biden’s nomination of Rahul Gupta, MD, MPH, MBA, FACP, to serve as the Director of the Office of National Drug Control Policy.

On May 19, 2021, ASTHO and Wanderly announced the launch of StaffUP, a new program for rapid, on-demand recruiting for governmental public health agencies.

On April 6, 2021, ASTHO released a Board-approved policy statement addressing structural racism as a necessary component in achieving optimal health for all.

On Jan. 15, 2021, ASTHO released a statement of support for President-Elect Joe Biden's American Rescue Plan, noting that the organization is looking forward to working collaboratively with the new administration to achieve the public ...

On Aug. 11, 2022, ASTHO's Chief Medical Officer issued a statement of support for CDC's new COVID-19 guidelines.

On Sept. 3, 2020, Rachel Levine, MD, ASTHO President and Secretary of Health for Pennsylvania, issued a statement of concern and called for rigorous scientific testing in response to comments from federal leadership that implied a COVID-19 ...

On Aug. 13, 2020, ASTHO and the National Coalition of STD Directors announced that their joint venture, Making Content: A Training for COVID-19 Contact Tracers has been awarded a Power of A Silver Award by the American Society of ...

On July 16, 2020, ASTHO announced the release of a COVID-19 issue guide that delves into the evolving role and function of technology in this pandemic response. Particularly as it relates to contact tracing, case investigation, and use of ...

On July 16, 2020, ASTHO announced that Pennsylvania Secretary of Health Rachel Levine, MD, has been appointed to the position of ASTHO President.

On June 23, 2020, Joneigh S. Khaldun, MD, MPH, the health official from Michigan, and an ASTHO member, testified before a Senate committee about the lessons learned so far from the COVID-19 pandemic.

On June 23, 2020, ASTHO CEO Michael Frasier and ASTHO president, and Arkansas secretary of health, Nathaniel Smith, MD, MPH issued a statement urging the American public to follow public health measures, such as wearing face coverings, to ...

On March 4, 2020, ASTHO member and Illinois state public health officer Ngozi Ezike, MD, testified about the COVID-19 pandemic response before a House committee.

On Feb. 10, 2020, ASTHO CEO Michael Fraser issued an assessment of President Trump's proposed fiscal year 2021 budget, particularly as it relates to public health efforts and funding.

On Feb, 5, 2020, ASTHO CEO Micheal Fraser issued a statement assuring Americans that governmental public health officials are equipped to face the challenge of preparing for and responding to the current novel coronavirus (COVID-19). ...

On Jan. 14, 2020, ASTHO members from Rhode Island and Massachusetts testified before a House subcommittee on state efforts to address the opioid epidemic.